Blueprint Medicines Corp

About Blueprint Medicines Corp

Blueprint Medicines Corporation is a global biopharmaceutical company focused on discovering, developing, and commercializing targeted therapies in allergy/inflammation and oncology/hematology. Its core products include AYVAKIT/AYVAKYT (avapritinib) for systemic mastocytosis and PDGFRA-mutant gastrointestinal stromal tumors. Leveraging proprietary drug design and research platforms, Blueprint targets disease drivers with small molecule inhibitors and protein degraders, serving patients worldwide through integrated R&D, clinical development, and commercial operations.